TC
AVNS icon

TFS Capital’s Avanos Medical AVNS Stock Holding History

TFS Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,962
Closed -$352K – 32
2017
Q2 		$352K Sell
8,962
-21,500
-71% -$812K 0.14% 295
2017
Q1 		$1.16M Sell
30,462
-11,082
-27% -$432K 0.38% 56
2016
Q4 		$1.54M Sell
41,544
-9,142
-18% -$327K 0.41% 37
2016
Q3 		$1.76M Buy
50,686
+23,329
+85% +$817K 0.42% 41
2016
Q2 		$890K Sell
27,357
-25,240
-48% -$773K 0.16% 206
2016
Q1 		$1.51M Sell
52,597
-16,885
-24% -$450K 0.22% 132
2015
Q4 		$2.32M Sell
69,482
-19,790
-22% -$615K 0.25% 128
2015
Q3 		$2.54M Buy
89,272
+44,425
+99% +$1.55M 0.24% 107
2015
Q2 		$1.82M Buy
+44,847
New +$2.01M 0.18% 172

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TFS Capital's AVNS Position: Q3 2017 in Review

TFS Capital sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 8,962 shares — an estimated $352K sold.

TFS Capital first reported a position in AVNS in Q2 2015 and held it in 9 quarters. The position peaked at $2.54M in Q3 2015. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • TFS Capital reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 8,962 Avanos Medical shares in Q3 2017, an estimated $352K.
  • TFS Capital first reported a position in Avanos Medical in Q2 2015 and held it in 9 quarters.
  • TFS Capital's Avanos Medical position peaked at $2.54M in Q3 2015.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.